Overview
The Therapeutic Goods (Information Specification—Manufacturing Inspections) Instrument 2026 is a new legal rule made under the Therapeutic Goods Act 1989. It sets out what information about manufacturing inspections of therapeutic goods can be released to the public.
The instrument registered on the Federal Register of Legislation on 23 October 2026 and is already in force.
What the Instrument Covers
The source text provided only includes the table of contents for this instrument. The listed sections cover name, commencement, authority, definitions, and release of information, plus a schedule on public release of information. The detailed content of those sections - including specific details on what information is released, to whom, or under what conditions - is not specified in this source.
Administration
This instrument is administered by the Department of Health, Disability and Ageing.
Who This Is Relevant To
This instrument is most relevant to businesses involved in manufacturing therapeutic goods, such as pharmaceutical, medical device, or supplement manufacturers.
Key Actions
- Visit https://www.legislation.gov.au/F2026L01412 to read the full legislative text and explanatory statement for details on what manufacturing inspection information will be released
- If a business manufactures therapeutic goods, check this instrument to understand what inspection information about its operations may now be made public
- Use the 'Set up an alert' or 'Save this title to My Account' options on the Federal Register of Legislation page to track any future amendments
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.